)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Lincoln Pharmaceuticals
Lincoln Pharmaceuticals (531633) investor relations material
Lincoln Pharmaceuticals Q2 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2027 earnings summary29 Oct, 2026
Executive summary
Q2 FY27 total income was ₹200.88 crore, up 17.75% YoY; H1 total income reached ₹402.43 crore, up 18.39% YoY.
H1 FY27 EBITDA rose 18.37% YoY to ₹84.92 crore; statement net profit was ₹56.66 crore versus ₹47.66 crore in H1 FY26.
Financial highlights
Q2 revenue from operations was ₹191.35 crore versus ₹177.28 crore YoY; Q2 total income was ₹200.88 crore versus ₹170.60 crore.
Q2 PBT was ₹29.02 crore versus ₹28.81 crore YoY; net profit was ₹20.43 crore versus ₹19.98 crore.
H1 PBT was ₹76.57 crore versus ₹64.20 crore; net profit was ₹56.66 crore versus ₹47.66 crore.
Media-release EBITDA was ₹33.22 crore in Q2 FY27 versus ₹32.66 crore, and ₹84.92 crore in H1 versus ₹71.74 crore.
Outlook and guidance
Targeting ₹1,000 crore revenue over the next three years and annual growth of 15–18%, supported by cardiac, diabetic, dermatology and ENT segments.
Plans to expand exports from 60+ countries to 90 over 2–3 years, register additional export products and grow in regulated and semi-regulated markets.
FY27 priorities include domestic and international expansion, leveraging manufacturing capacity and the product pipeline; women's healthcare and dermatology are focus areas.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Lincoln Pharmaceuticals
- Sales grew 23%, while Khatraj delays constrained results and the expansion outlook.531633
Q4 96/97 - Profit improved YoY, but delayed expansion and recession kept results well below plan.531633Q4 97/98
- Sales and profit grew, but operating cash flow swung negative.531633Q4 98/99
- FY2000 sales and net profit rose; exports fell and no dividend was proposed.531633Q4 99/00
- Sales rose to Rs 3,356.16 lacs and net profit to Rs 144.24 lacs in FY03.531633Q4 02/03
- Sales and net profit advanced as expansion plans faced competition and rising costs.531633Q4 03/04
- Sales grew, but profit fell; a 12% dividend and cautious growth plans followed.531633Q4 04/05
- Sales rose 49% as PAT grew, with new products and job work targeted for further growth.531633Q4 05/06
- Sales rose 12.25% as PAT increased to Rs 304.76 lakh amid competitive pressure.531633Q4 06/07
Next Lincoln Pharmaceuticals earnings date
Q3 26/2711 Feb, 2027
Lincoln Pharmaceuticals
Next Lincoln Pharmaceuticals earnings date
Q3 26/2711 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Lincoln Pharmaceuticals Limited is a pharmaceutical company engaged in the development, manufacturing, and marketing of pharmaceutical formulations. The company produces a wide range of dosage forms including tablets, capsules, injectables, creams, and syrups across various therapeutic categories such as anti-infectives, gastrointestinal, cardiovascular, and dermatology. It serves both domestic and international markets and operates manufacturing facilities that comply with regulatory standards. Lincoln Pharmaceuticals Limited also provides contract manufacturing services to other pharmaceutical companies. The company is headquartered in Ahmedabad, India, and its shares are listed on the BSE.